Case Report

A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast

Volume 1 · Issue 4 Publish Date: September 3, 2019
Full Text PDF
DOI
Gözde Yıldırım Çetin
Department of Rheumatology, Sütçü İmam University Faculty of Medicine, Kahramanmaraş, Turkey
Hayriye Sayarlıoğlu
Department of Nephrology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
Çiğdem Erhan
Department of Internal Medicine, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Hasan Kahraman
Department of Chest Diseases, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Harun Cıralık
Department of Pathology, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Mehmet Sayarlıoğlu
Department of Rheumatology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
Yıldırım Çetin, G., Sayarlıoğlu, H., Erhan, Çiğdem, Kahraman, H., Cıralık, H., & Sayarlıoğlu, M. (2019). A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast. European Journal of Rheumatology, 1(4), 170–171. https://doi.org/10.5152/eurjrheumatol.2014.140032
Full Text Full Text PDF

Abstract

Abstract

In this case report, we present a female patient with neutrophilic dermatosis (ND) occurring as palpable purpura after using montelukast. Neutrophilic dermatoses (NDs) are characterized by skin lesions in which mature neutrophils are predominantly located in the epidermis and dermis in the absence of any infective pathology. Classification of the NDs is based upon the recognition of clinical and pathologic features, as well as the identification of associated diseases, like Sweet’s syndrome, pyoderma gangrenosum, generalized pustular psoriasis, and Behçet’s disease. Cutaneous findings in NDs are variable and can include vesiculopustules, plaques, nodules, or ulcerations. Drug-induced NDs are not uncommon, but ND with palpable purpura is uncommon. The current patient appeared with a rare presentation as palpable purpura without vasculitis regarding ND. It is important that this is the first case report.

 

Article Info
Published In
Journal European Journal of Rheumatology
Volume / Issue Volume 1 · Issue 4
Pages 170-171
History
Published Online September 3, 2019
Copyright
Affiliations
Gözde Yıldırım Çetin
Department of Rheumatology, Sütçü İmam University Faculty of Medicine, Kahramanmaraş, Turkey
Hayriye Sayarlıoğlu
Department of Nephrology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
Çiğdem Erhan
Department of Internal Medicine, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Hasan Kahraman
Department of Chest Diseases, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Harun Cıralık
Department of Pathology, Sütçü İmam University Facultry of Medicine, Kahramanmaraş, Turkey
Mehmet Sayarlıoğlu
Department of Rheumatology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
Cite this Article
Yıldırım Çetin, G., Sayarlıoğlu, H., Erhan, Çiğdem, Kahraman, H., Cıralık, H., & Sayarlıoğlu, M. (2019). A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast. European Journal of Rheumatology, 1(4), 170–171. https://doi.org/10.5152/eurjrheumatol.2014.140032
Share
Outlines